Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Reagila“
Suchtreffer
Begriffe & Kennungen
Reagila · 4.8 Undesirable effects · 2
Eintrag öffnenReagila · 4.8 · 10 patients treated with cariprazine, versus 2.0% in the placebo group. Parkinsonism was experienced in 7.8% a
Eintrag öffnenReagila · 4.8 · 26 Libido increased Erectile dysfunction Nervous Akathisia2 Sedation Tardive Seizures/ Neuroleptic system Park
Eintrag öffnenReagila · 4.8 · 27 Renal and Dysuria urinary Pollakisuria disorders Pregnancy, Drug puerperium withdrawal and syndrome perinat
Eintrag öffnenReagila · 4.8 · 28 Venous thromboembolism (VTE) Cases of VTE, including cases of pulmonary embolism and cases of deep vein thr
Eintrag öffnenReagila · 4.8 · 8 disorders Decreased mellitus appetite Blood glucose Increased increased appetite Psychiatric Sleep Suicidal
Eintrag öffnenReagila · 4.8 · 9 Skin and Pruritus subcutaneou Rash s tissue disorders Musculoskel Blood creatine Rhabdomyoly etal and phosph
Eintrag öffnenReagila · 4.8 · ADRs based upon pooled data from cariprazine schizophrenia studies are shown by system organ class and by pref
Eintrag öffnenReagila · 4.8 · ADRs based upon pooled data from cariprazine schizophrenia studies are shown by system organ class and by pref
Eintrag öffnenReagila · 4.8 · Adverse reactions are ranked by MedDRA system organ class and by frequency, the most frequent first, using the
Eintrag öffnenReagila · 4.8 · Adverse reactions are ranked by MedDRA system organ class and by frequency, the most frequent first, using the
Eintrag öffnenReagila · 4.8 · Description of selected adverse reactions
Eintrag öffnenReagila · 4.8 · Description of selected adverse reactions
Eintrag öffnenReagila · 4.8 · Elevated liver transaminases Elevated liver transaminases (Alanine Aminotransferase [ALT], Aspartate Aminotran
Eintrag öffnenReagila · 4.8 · Elevated liver transaminases Elevated liver transaminases (Alanine Aminotransferase [ALT], Aspartate Aminotran
Eintrag öffnenReagila · 4.8 · Extrapyramidal symptoms (EPS) In the short-term studies the incidence of EPS was observed in 27%; 11.5%; 30.7%
Eintrag öffnenReagila · 4.8 · Extrapyramidal symptoms (EPS) In the short-term studies the incidence of EPS was observed in 27%; 11.5%; 30.7%
Eintrag öffnenReagila · 4.8 · In the negative symptom study EPS was reported in 14.3% in the cariprazine group and 11.7% in the risperidone
Eintrag öffnenReagila · 4.8 · In the negative symptom study EPS was reported in 14.3% in the cariprazine group and 11.7% in the risperidone
Eintrag öffnenReagila · 4.8 · In the placebo-controlled part of the long-term maintenance of effect study EPS was 13.7% in the cariprazine g
Eintrag öffnen